Assembly Biosciences, Inc.
CYCLIC SULFAMIDE COMPOUNDS FOR TREATMENT OF HBV

Abstract:

The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.